The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
about
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.Role of cysteine‑rich angiogenic inducer 61 in fibroblast‑like synovial cell proliferation and invasion in rheumatoid arthritis.Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.Interleukin-34 in rheumatoid arthritis: potential role in clinical therapy.The Inhibitory Effect of C-phycocyanin Containing Protein Extract (C-PC Extract) on Human Matrix Metalloproteinases (MMP-2 and MMP-9) in Hepatocellular Cancer Cell Line (HepG2).Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis.Expression of matrix metalloproteinases and components of the endocannabinoid system in the knee joint are associated with biphasic pain progression in a rat model of osteoarthritisSerum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.An update on biomarker discovery and use in axial spondyloarthritis.The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.Berberis aristata Ameliorates Adjuvant-Induced Arthritis by Inhibition of NF-κB and Activating Nuclear Factor-E2-related Factor 2/hem Oxygenase (HO)-1 Signaling Pathway.Single intra-articular dexamethasone injection immediately post-surgery in a rabbit model mitigates early inflammatory responses and post-traumatic osteoarthritis-like alterations.Matrix Metalloproteases as Biomarkers of Disease.
P2860
Q34043042-864D8BE1-930A-42F1-AE8A-BDC0608F91C4Q34673358-BD56E0D8-04EC-464D-AD28-169950165968Q35809286-0535ABA4-098E-4DD1-8D8A-A8279AA8A424Q35870921-A63DBB15-FF1F-4341-BBE8-4EB4D05945AFQ38709646-98C55C0D-E0A0-4617-A8B3-D19CC7947C55Q39844159-775F6F22-EB56-496B-BC8D-2AB5761FA544Q41531870-7508C28D-5E60-4E12-9015-033E4D5EEF81Q41690873-32914A94-7A8F-4E9A-9D52-8EDF77385021Q47787817-DE9F7ABC-BEEB-4C05-90BB-097541F60B3AQ47981156-5E8AD074-BAB8-47EA-AC74-0B8812D8BCBCQ51617740-823AD9E1-58C2-4F4C-A3A8-63566436D652Q51706270-84F8B900-A48A-469B-944B-11C5CA401890Q53192556-34F702F4-0433-415A-A187-42EB3E72CC4AQ53747809-619D8987-A91F-404E-AD03-3BF9E29B29B5
P2860
The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@ast
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@en
type
label
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@ast
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@en
prefLabel
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@ast
The active form of MMP-3 is a ...... n inflammatory joint diseases.
@en
P2093
P2860
P356
P1476
The active form of MMP-3 is a ...... in inflammatory joint diseases
@en
P2093
Anne-Christine Bay-Jensen
Kim Henriksen
Morten A Karsdal
Qinlong Zheng
Thorbjørn G Christiansen
Walter P Maksymowych
P2860
P2888
P356
10.1186/1471-2474-15-93
P577
2014-03-19T00:00:00Z
P5875
P6179
1038199685